Skip to content

Prognostic Factors in Periampullary Tumors and Cysts

Prognostic Factors, Operative Care and Short and Long Term Outcomes for Cysts and Tumors in Pancreas and the Periampullary Region

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05155878
Enrollment
500
Registered
2021-12-14
Start date
2021-09-01
Completion date
2040-01-01
Last updated
2022-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bile Duct Cancer, Pancreas Cancer, Pancreas Cyst, Pancreas Disease, Pancreas Neoplasm, Pancreatic Fistula, Periampullary Cancer, Surgery, Surgery--Complications

Brief summary

The project aims at analysing prognostic and predictive factors involved in diagnostics and surgical treatment of cysts and tumors in the pancreas and periampullary region using both clinical data and blood and tissue samples for biomarker development and validation.

Detailed description

From november 2021 an onward, study participants will be prospectively enrolled within the observational study. Before that, study participants are retrospectively enrolled. The study has a broad perspective including studies on clinical outcomes and prognostics based on patient and tumor characteristics.

Interventions

None listed

Sponsors

Umeå University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Recommended surgery for tumor or cyst in the pancreas or periampullary region * Information avalible in electronic journal files * Informed consent (or deceased for retrospective part of the study)

Exclusion criteria

* No informed consent (and still alive at study initiation)

Design outcomes

Primary

MeasureTime frameDescription
Overall survival10 yearsOverall survival

Secondary

MeasureTime frameDescription
Complications10 yearsClavien-Dindo, Specific procedure related outcomes
Radical resection10 yearsRates of R0 vs R1/2 resections

Countries

Sweden

Contacts

Primary ContactOskar Franklin, MD/PhD
oskar.franklin@umu.se+4690785000
Backup ContactAsif Halimi, MD
asif.halimi@regionvasterbotten.se+4690785000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026